Catheter system designed to treat blocked or damaged leg veins that have previously been stented and fail to return blood ...

A groundbreaking study from the University of Cambridge reveals a new drug that can significantly reduce brain damage caused ...

Cambridge scientists have developed and tested a new drug in mice that has the potential to reduce damage to the brain when blood flow is restored following a stroke.

A Donegal woman has become the first patient in the world to receive a ground-breaking treatment at University Hospital Galway.

Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...

Cambridge scientists have developed and tested a new drug in mice that has the potential to reduce damage to the brain when ...

Key Points Penumbra topped analyst forecasts with $339.5 million in GAAP revenue and $0.86 non-GAAP EPS, driven by double-digit U.S. thrombectomy growth. Gross margin (GAAP) expanded sharply to 66.0%, ...

Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second ...

Stryker just rolled out its next-generation InThrill Thrombectomy System, and it’s turning heads in the medical community.